CytomX Therapeutics Inc. (CTMX)
NASDAQ:CTMX
Want to see CTMX full AI Analyst Report?
CytomX Therapeutics (CTMX) Ownership Overview
0.91% Insiders
14.85% Mutual Funds
35.20% Other Institutional Investors
8.66% ETFs
40.38% Public Companies and
Individual Investors
The ownership structure of CytomX Therapeutics (CTMX) stock is a mix of institutional, retail, and individual investors. Approximately 58.71% of the company’s stock is owned by Institutional Investors, 0.91% is owned by Insiders, and 40.38% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 19, 2026 | xxxxxxxxxxxxx | $124054 | |
Mar 19, 2026 | xxxxxxxxxxxxx | $202179 | |
Mar 19, 2026 | xxxxxxxxxxxxx | $136611 | |
Mar 19, 2026 | xxxxxxxxxxxxx | $763781 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2024 | xxxxxxxxxxxxx | $9403878 | |
Sep 30, 2024 | xxxxxxxxxxxxx | $23386382 | |
Sep 30, 2024 | xxxxxxxxxxxxx | $47464473 | |
Sep 30, 2024 | xxxxxxxxxxxxx | $5265452 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,098,824 | Institution | 4.64% | 30,397,460 | |
| 9,033,371 | Institution | 4.15% | 27,190,447 | |
| 8,524,691 | Institution | 3.92% | 25,659,320 | |
| 7,454,335 | Institution | 3.42% | 22,437,548 | |
| 5,193,787 | Institution | 2.39% | 15,633,299 | |
| 4,975,826 | Institution | 2.29% | 14,977,236 | |
| 4,622,540 | Institution | 2.12% | 13,913,845 | |
| 3,896,582 | Institution | 1.79% | 11,728,712 | |
| 3,222,510 | Institution | 1.48% | 9,699,755 | |
| 3,100,251 | Institution | 1.42% | 9,331,756 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,524,691 | Institution | 3.92% | 25,659,320 | |
| 7,454,335 | Institution | 3.42% | 22,437,548 | |
| 4,622,540 | Institution | 2.12% | 13,913,845 | |
| 3,222,510 | Institution | 1.48% | 9,699,755 | |
| 3,100,251 | Institution | 1.42% | 9,331,756 | |
| 2,038,411 | Institution | 0.94% | 6,135,617 | |
| 900,000 | Institution | 0.41% | 2,709,000 | |
| 700,570 | Institution | 0.32% | 2,108,716 | |
| 453,100 | Institution | 0.21% | 1,363,831 | |
| 371,652 | Institution | 0.17% | 1,118,673 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,531,787 | Institution | 3.00% | 27,564,141 | |
| 5,029,815 | Institution | 2.31% | 14,988,849 | |
| 2,018,855 | Institution | 0.93% | 8,519,568 | |
| 1,263,886 | Institution | 0.58% | 3,804,297 | |
| 601,083 | Institution | 0.28% | 1,809,260 | |
| 482,729 | Institution | 0.22% | 2,037,116 | |
| 290,427 | Institution | 0.13% | 1,225,602 | |
| 239,440 | Institution | 0.11% | 713,531 | |
| 233,927 | Institution | 0.11% | 697,102 | |
| 231,758 | Institution | 0.11% | 697,592 |
FAQ
Who Owns CytomX Therapeutics Inc. (CTMX)?
According to the latest TipRanks data, approximately 35.20% of the company's stock is held by institutional investors, 0.91% is held by insiders, and 40.38% is held by retail investors.
What percentage of CytomX Therapeutics Inc. (CTMX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 35.20% of CytomX Therapeutics Inc. (CTMX) stock is held by institutional investors.
What percentage of CytomX Therapeutics Inc. (CTMX) stock is held by retail investors?
According to the latest TipRanks data, approximately 40.38% of CytomX Therapeutics Inc. (CTMX) stock is held by retail investors.
Who owns the most shares of CytomX Therapeutics Inc. (CTMX)?
Joseph Edelman owns the most shares of CytomX Therapeutics Inc. (CTMX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.